TREA

90696853 - REVERSIR

Follow

Information

  • Trademark
  • 90696853
  • Serial Number
    90696853
  • Filing Date
    May 07, 2021
    3 years ago
  • Transaction Date
    March 30, 2022
    2 years ago
  • Status Date
    March 29, 2022
    2 years ago
  • Published for Opposition Date
    January 25, 2022
    2 years ago
  • Location Date
    March 29, 2022
    2 years ago
  • Status Code
    605
  • Current Location
    GENERIC WEB UPDATE
    Employee Name
    BLANE, SUZANNE M
  • Law Office Assigned Location Code
    M50
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
REVERSIR
Case File Statements
  • GS0051: Pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection; Pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection
  • PM0001: REVERSER
Case File Event Statements
  • 3/30/2022 - 2 years ago
    16 - ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION Type: MAB5
  • 3/29/2022 - 2 years ago
    15 - ABANDONMENT - AFTER PUBLICATION Type: ABN5
  • 3/23/2022 - 2 years ago
    14 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 3/23/2022 - 2 years ago
    13 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 3/23/2022 - 2 years ago
    12 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 3/23/2022 - 2 years ago
    11 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 3/23/2022 - 2 years ago
    10 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 3/23/2022 - 2 years ago
    9 - TEAS EXPRESS ABANDONMENT RECEIVED Type: EXAR
  • 2/16/2022 - 2 years ago
    8 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 1/25/2022 - 2 years ago
    7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/25/2022 - 2 years ago
    6 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/5/2022 - 2 years ago
    5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/18/2021 - 2 years ago
    4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/18/2021 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/9/2021 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 5/11/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP